top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
On April 23, 2026, Acting Attorney General Todd Blanche announced the reclassification of state-licensed medical marijuana and FDA-approved marijuana products from Schedule I to Schedule III of the Controlled Substances Act. This action, following a December 2025 executive order from President Trump, aims to expand research and medical access while allowing state-licensed businesses to claim federal tax deductions previously barred under IRS code 280E. While the order immediately affects medical and FDA-approved products, an expedited administrative hearing is scheduled for June 29 to consider the broader rescheduling of all marijuana.

The Feds are Officially Making Moves to Reclassify Cannabis to Schedule III

Apr 23, 2026

Source:

Tom Angell

Marijuana Moment

The federal government is finally taking a massive step toward modernizing its approach to cannabis. In a move that has been anticipated for years, the Department of Justice is moving forward with a plan to reclassify our favorite plant from the most restrictive category, Schedule I, to the much more manageable Schedule III. This shift, initiated by the current administration, effectively ends the era of treating cannabis with the same severity as heroin or LSD at the federal level.

So, what does this actually mean for the average enthusiast? For starters, it’s a huge win for transparency and safety. By moving to Schedule III, the government is acknowledging that cannabis has accepted medical uses. This reclassification will sweep away many of the bureaucratic hurdles that have historically blocked scientists from studying the plant’s full benefits. In the long run, this means more reliable data and even better products appearing on your local dispensary shelves as cultivators gain access to professional research.

Beyond the lab, this is a game-changer for the local shops we all support. Currently, many cannabis businesses are crushed by a dated tax rule known as 280E, which prevents them from deducting standard business expenses. Moving to Schedule III should eliminate this burden, allowing local brands and dispensaries to reinvest that money back into their staff, their facilities, and the community experience. It’s a major relief for an industry that has been operating with one hand tied behind its back.

While we aren't at full federal legalization just yet, the momentum is undeniable. This update serves as a powerful signal that the reefer madness mentality is becoming a thing of the past. For anyone who uses cannabis for wellness or recreation, this is a moment to celebrate. It’s a huge leap toward a future where the plant we love is treated with the respect and common sense it deserves. Keep an eye on your favorite local budtenders for updates as these changes begin to trickle down to the retail level.

Recent Reviews

bottom of page